Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases

Carregando...
Imagem de Miniatura
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS INC
Citação
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, v.21, n.3, p.211-216, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Sweet syndrome (SS) is an infrequent skin disease characterised by sudden onset of fever, leukocytosis, neutrophilia, and tender erythematous plaques infiltrated by neutrophils. Multiple conditions have been associated with this syndrome. Objectives: The aim of this study was to evaluate the clinical, epidemiological, laboratory, and histopathological findings and associations of patients with SS. Methods: We conducted a retrospective study of 83 patients with SS followed between January 1, 2006, and January 31, 2015. Results: Of the patients, 82% were female; the mean age at onset was 48 years. Clinical presentation was mainly characterised by erythematous and edematous plaques, mostly on upper extremities and trunk. Fever was observed in 32%; 60% presented leukocytosis and 39% neutrophilia. On histopathological examination, neutrophilic and lymphohistiocytic infiltrate and edema were the most frequent findings. Fourteen percent of patients had malignancy or hematologic disorders, 26% were classified as having drug-induced SS, and 24% noted recent infection. Only 2 cases occurred during pregnancy. Systemic corticosteroid was the most common choice of treatment, with excellent response. In malignancy-associated SS, the mean hemoglobin level was lower (P = .01) and the erythrocyte sedimentation rate (ESR) was higher (P = .04) in comparison to classic and drug-induced SS. Leukocytoclasia was associated with higher risk of recurrence (P = .01). Conclusion: All patients with SS deserve careful investigation of possible underlying conditions. Higher ESR and lower hemoglobin levels might reinforce the need of malignancy screening. Also, leukocytoclasia appears to be a potential marker of higher recurrence rate, demanding closer and longer follow-up.
Palavras-chave
Sweet syndrome, neutrophilic dermatosis, erythematous plaques, paraneoplastic phenomenon, drug-induced, fever, leukocytosis
Referências
  1. Anzalone CL, 2013, CURR OPIN HEMATOL, V20, P26, DOI 10.1097/MOH.0b013e32835ad132
  2. Bourke JF, 1997, BRIT J DERMATOL, V137, P609, DOI 10.1111/j.1365-2133.1997.tb03796.x
  3. Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34
  4. Cohen Philip R, 2002, Am J Clin Dermatol, V3, P117, DOI 10.2165/00128071-200203020-00005
  5. COHEN PR, 1993, CLIN DERMATOL, V11, P149, DOI 10.1016/0738-081X(93)90112-P
  6. Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590
  7. Eleuterio IA, 2012, AN BRAS DERMATOL, V87, P450, DOI 10.1590/S0365-05962012000300014
  8. ESCALLIER F, 1990, ANN DERMATOL VENER, V117, P858
  9. Kluger N, 2011, DERMATOLOGY, V222, P123, DOI 10.1159/000326112
  10. Kolb-Maurer A, 2013, J DTSCH DERMATOL GES, V11, P1200, DOI 10.1111/ddg.12172
  11. Lallas A, 2011, HIPPOKRATIA, V15, P283
  12. Malone JC, 2002, ARCH DERMATOL, V138, P345, DOI 10.1001/archderm.138.3.345
  13. Masmoudi A, 2007, PRESSE MED, V36, P419, DOI 10.1016/j.lpm.2006.07.010
  14. Nocente R, 2002, PANMINERVA MED, V44, P149
  15. Ratzinger G, 2007, AM J DERMATOPATH, V29, P125, DOI 10.1097/01.dad.0000249887.59810.76
  16. Raza S, 2013, INT J ONCOL, V42, P1516, DOI 10.3892/ijo.2013.1874
  17. Reina CO, 1998, OTOLARYNG HEAD NECK, V119, P709, DOI 10.1016/S0194-5998(98)70042-7
  18. Rochael MC, 2011, AN BRAS DERMATOL, V86, P702, DOI 10.1590/S0365-05962011000400012
  19. Rochet NM, 2013, J AM ACAD DERMATOL, V69, P557, DOI 10.1016/j.jaad.2013.06.023
  20. SATRA K, 1994, J AM ACAD DERMATOL, V30, P297, DOI 10.1016/S0190-9622(08)81068-7
  21. SU WPD, 1986, CUTIS, V37, P167
  22. SWEET RD, 1964, BRIT J DERMATOL, V76, P349, DOI 10.1111/j.1365-2133.1964.tb14541.x
  23. VONDENDRIESCH P, 1994, J AM ACAD DERMATOL, V31, P535
  24. Walker DC, 1996, J AM ACAD DERMATOL, V34, P918, DOI 10.1016/S0190-9622(96)90080-8
  25. Weedon D., 2010, WEEDONS SKIN PATHOLO, P195, DOI 10.1016/B978-0-7020-3485-5.00009-7
  26. White JML, 2006, CLIN EXP DERMATOL, V31, P206, DOI 10.1111/j.1365-2230.2005.01996.x
  27. Ytting H, 2005, DIGESTION, V72, P195, DOI 10.1159/000088466